Beth Israel Deaconess Medical Center

What Beth Israel Deaconess Medical Center does

Beth Israel Deaconess Medical Center (BIDMC) is a private nonprofit academic medical center and Level 1 trauma center founded in 1996 and located in Boston, Massachusetts, operating as a subsidiary of the Beth Israel Lahey Health (BILH) integrated delivery system that spans 16+ hospitals and facilities. The institution functions as a major Harvard Medical School teaching affiliate, employing 5,001-10,000 staff and supporting approximately 350 postdoctoral scholars, with 600+ physicians recognized across Top Doctors guides. BIDMC provides comprehensive inpatient and outpatient services across core specialties including cancer care, heart care, behavioral health, organ transplant, surgery, emergency medicine, primary care, urgent care, and a high-volume pathology department that processes 50,000 tissue specimens and 8 million laboratory tests annually.

The medical center's technology footprint includes AI diagnostic research, spatial transcriptomics (Illumina StrataMap pilot), CAR T cell therapy, robotic surgery, CRISPR gene-editing research, and a 'pencil beam' laser imaging collaboration with MIT. Proprietary research outputs include the BODHI AI confidence assessment framework, AI-TEW mortality prediction framework, and a published Lancet typology of AI-associated psychotic phenomena. BIDMC serves as first-of-its-kind clinical validation site for external AI systems including Google DeepMind's AMIE conversational diagnostic AI, OpenAI's o1 reasoning model, and CLAIRITY BREAST cancer risk prediction, and has been designated a Singular Genomics G4X Center of Excellence.

BIDMC's business model is a multi-stream nonprofit operating model funded by patient care services (insurance, Medicare, Medicaid, self-pay), NIH and federal research grants, pharmaceutical and foundation clinical trial funding, and philanthropic donations. GTM is sales-led, with patients accessing services through direct primary care, specialist referrals, emergency intake, and a 24/7 BILH Transfer Center handling external transfers. Pricing is CMS-mandated price-transparent with an interactive cost calculator for shoppable services plus a financial assistance program. Distribution spans the main Boston campus (330 Brookline Avenue), East and West campus labs, and suburban lab locations in Chelsea, Chestnut Hill, and Lexington, with the MyBILH Chart patient portal enabling digital patient engagement. The institution is materially expanding through a $1.8 billion 300-bed cancer hospital collaboration with Dana-Farber Cancer Institute opening in 2031.

Name

Beth Israel Deaconess Medical Center

Legal name

Beth Israel Deaconess Medical Center

Website

https://bidmc.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Beth Israel Deaconess Medical Center is a Harvard Medical School-affiliated nonprofit academic medical center in Boston providing comprehensive inpatient, outpatient, and specialty care across oncology, cardiology, behavioral health, and pathology as part of the Beth Israel Lahey Health system.

Ownership category

akta.pro rank

Product category

Academic Medical Center / Hospital Services

NAICS

Hospitals (622), General Medical and Surgical Hospitals (62211)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industry

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

Keywords

• Academic medical center
• Teaching hospital services
• Cancer care treatment
• Pathology laboratory services
• Behavioral health treatment

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue generated from comprehensive healthcare services including primary care, specialty care, emergency services, surgical procedures, diagnostic testing, and inpatient/outpatient care. Services covered by insurance, Medicare, Medicaid, and self-pay patients.
2. Research Grants and Clinical Trials: Funding from NIH, federal agencies, pharmaceutical companies, and foundations for clinical research and trials.
3. Philanthropy and Donations: Charitable contributions from donors supporting groundbreaking research, education, and patient care programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Beth Israel Deaconess Medical Center is an academic medical center and primary teaching hospital of Harvard Medical School that delivers comprehensive inpatient and outpatient clinical care across specialties including cancer, heart, surgery, emergency medicine, behavioral health, primary care, organ transplant, urology, pregnancy, breast health, urgent care, and laboratory/pathology. As part of the Beth Israel Lahey Health system, it integrates patient care with biomedical research (AI diagnostics, spatial transcriptomics, CRISPR, gene therapy) and medical education programs supporting 350+ postdoctoral scholars.

Product overview

Beth Israel Deaconess Medical Center (BIDMC) is a Harvard Medical School teaching hospital providing comprehensive inpatient and outpatient healthcare services across multiple specialties. The institution operates as a unified healthcare delivery platform rather than a software product company, offering clinical services including cancer care, heart care, emergency medicine, surgery, behavioral health, laboratory/pathology services, urology, organ transplant, primary care, and urgent care. BIDMC also provides patient-facing digital services including MyBILH Chart patient portal and BILH Text System for appointment and billing communications. The medical center collaborates with research partners including Google, Illumina, and Singular Genomics for AI-driven diagnostics and spatial technologies. BIDMC supports medical education through postdoctoral training, faculty career development, and continuing education programs, and operates community programs including a Summer Youth Jobs internship. The organization is expanding its cancer care capabilities through a collaboration with Dana-Farber Cancer Institute to build a new dedicated cancer hospital by 2031.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Care
• Heart Care
• Laboratory & Pathology Services
• Behavioral Health
• Urology Services
• Organ Transplant & Donation
• Surgery
• Emergency Care
• Primary Care
• Urgent Care
• Pregnancy & Birth Services
• Breast Health
• Surgical Pathology Consultation Service
• MyBILH Chart Patient Portal

Quantifiable outcome

• AI achieved 67% diagnostic accuracy at triage versus 50-55% for physicians in 76 real ER cases
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability16 records

Feature8 records

Partnerships

14 partnerships are on record, tiered core, minor, strategic and flagship.

• IlluminacoreTechnology or Integration · 8 June 2026Pilot research partnership using Illumina's StrataMap Spatial Solution for spatial whole-transcriptome studies. Demonstrated applications in mapping tumor microenvironments and complex tissues at single-cell resolution.
• NeuroXTcoreStrategic or Co-development Partner · 26 May 2026Biotechnology partnership for AI-driven neuroimaging biomarkers and precision treatment of Alzheimer's disease. Initial research validated MRI-based AI technology for estimating Alzheimer's PET biomarkers. Expanded collaboration extends to patients who have received Alzheimer's therapies for over one year.
• Amplified SciencesminorStrategic or Co-development Partner · 14 May 2026Principal investigator involvement in PanAMP multicenter clinical utility study for PanCystPro diagnostic assay evaluating healthcare provider management decisions for pancreatic cystic lesions.
• OpenAIcoreStrategic or Co-development Partner · 4 May 2026Research collaboration demonstrating that OpenAI's o1-preview reasoning model matched or exceeded physician diagnostic accuracy in 76 real emergency room cases. Study published in Science journal.
• MITcoreStrategic or Co-development Partner · 28 April 2026Collaborative research on 'pencil beam' laser imaging technique for brain imaging, enabling 25 times faster 3D imaging of the blood-brain barrier.
• Google Research and Google DeepMindcoreStrategic or Co-development Partner · 12 March 2026First-of-its-kind prospective feasibility study of AMIE conversational diagnostic AI involving 100 adult patients in primary care. Study found zero safety stops across all interactions and 90% diagnostic accuracy.
• Singular GenomicsstrategicTechnology or Integration · 12 March 2026Designation as G4X Center of Excellence for spatial technologies, building on role as first G4X Early Access Program site. Partnership aims to help researchers run reproducible G4X studies at scale.
• Clairity Inc.strategicStrategic or Co-development Partner · 23 February 2026First clinical deployment of FDA-authorized CLAIRITY BREAST AI technology for predicting five-year breast cancer risk from mammograms. First institutional partner for Clairity's AI-powered breast cancer risk assessment.
• Dana-Farber Cancer InstituteflagshipStrategic or Co-development Partner · 4 February 2026Major collaboration to build a 300-bed inpatient cancer hospital in Boston's Longwood Medical Area, part of a $1.8 billion project. The facility, expected to open in 2031, will be one of only 14 inpatient cancer hospitals in the US. Funded in part by the largest single gift in Dana-Farber's history from Bekenstein and Lavine families.
• National Alliance on Mental Illness (NAMI)strategicStrategic or Co-development Partner · 18 November 2025Partnership project to develop benchmarks for assessing AI mental health tools' safety, accuracy, and cultural responsiveness. Includes Dr. John Torous from BIDMC in leadership.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerPrimary teaching affiliate of Harvard Medical School. Faculty members hold appointments at HMS and participate in medical education, research, and clinical care programs.
• Joslin Diabetes CentercoreStrategic or Co-development PartnerAffiliation with world-class Joslin Diabetes Center for diabetes treatment and research, part of comprehensive diabetes care ecosystem.
• Columbia University Irving Medical CenterstrategicStrategic or Co-development PartnerCollaborative research network with Peter Brodeur of BIDMC and Emily Tat of Columbia to provide independent evaluation infrastructure for clinical AI devices.
• Cancer Research UK Cambridge InstituteminorStrategic or Co-development PartnerCo-pilot institution with BIDMC for Illumina's StrataMap Spatial Solution demonstrating spatial transcriptomics applications.

Scale indicators11 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Dana-Farber Cancer Institute: Specialty cancer hospital and BIDMC's primary oncology collaboration partner. The $1.8B joint inpatient cancer hospital makes Dana-Farber a near-perfect peer for oncology research, clinical trials and cancer care delivery.
• Massachusetts General Hospital: Harvard Medical School's other primary teaching hospital in Boston. Operates as a similarly sized AMC with comprehensive specialty care, large research enterprise and Level 1 trauma services — directly comparable to BIDMC's mission, scale and patient mix.
• NYU Langone Health: Major NYC AMC combining tertiary hospital care, medical education and substantial NIH-funded research. Closely comparable to BIDMC in scope of clinical services, academic mission and digital health investment.
• Johns Hopkins Hospital: Top-tier U.S. academic medical center with comparable research funding, specialty depth and teaching role. Direct comparator for BIDMC in global rankings, NIH funding and specialty reputation.
• Mount Sinai Health System: NYC-based AMC with seven hospital campuses and an integrated research enterprise (Icahn School of Medicine). Comparable scale, teaching mission and broad specialty portfolio to BIDMC.
• Brigham and Women's Hospital: Harvard-affiliated AMC in Boston's Longwood Medical Area, offering comparable tertiary/quaternary care, research output and teaching role. Strongest direct competitor for complex cases and specialty referrals in the same metro.
• UCSF Medical Center: West Coast research AMC with strong AI/digital health programs, precision medicine initiatives and academic medical center structure. Comparable to BIDMC on research intensity and innovation pipeline.
• Northwestern Memorial Hospital: Mid-to-large AMC affiliated with Northwestern University Feinberg School of Medicine, offering similar tertiary care, research portfolio and urban quaternary hospital scale as BIDMC.
• Stanford Health Care: Major research-driven AMC with deep AI/biotech collaborations and an integrated academic enterprise. Similar to BIDMC's profile as an innovation-focused academic medical center tied to a top-tier medical school.
• Hospital of the University of Pennsylvania (Penn Medicine): Ivy League-affiliated AMC with comparable research intensity, transplant and oncology programs, and broad quaternary services. Comparable to BIDMC on academic mission and clinical complexity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/bidmchealth
• Xx.com/BIDMChealth

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beth Israel Deaconess Medical Center